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ABSTRACT 
DNA methylation, an epigenetic mechanism is claimed to play essential roles in development, 
aging and disease over the past few decades. Cytosines (C) were known to exist in two func-
tional states: unmethylated or methylated (5mC) in the mammalian genome for a very long 
time. However, the mechanisms controlling 5mC dynamics remain undefined. Recent studies 
of genomic DNA on human and mouse brain, neurons and from mouse embryonic stem cells 
have shown that 2-oxoglutarate and Fe(II)-dependent oxygenases of the ten-eleven transloca-
tion (Tet) proteins can catalyze the oxidation of 5mC at cpG dinucleotides to form 5-
hydroxymethylcytosine (5-hmC). The exhilarating discovery of these novel 5-hmC has begun 
to focus on the dynamic nature of 5mC. The prevailing evidence has shown that Tet family 
proteins and 5-hmC are involved in the normal development as well as in many diseases. This 
review presents an overview of the role of Tet family proteins and 5-hmC. It also discusses 
their role as an epigenetic marker and the techniques used for their analysis. 
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INTRODUCTION 
DNA methylation, i.e., methylation of 
cytosine at CpG sequences, and, to a lesser 
extent, in CpHpG or CpHpH (where H is A, 
C or T) sequences, is an epigenetic modifica-
tion linked to gene expression, regulation 
and developmental processes in various eu-
karyotes (Bird, 2002; Feng et al., 2010; He et 
al., 2011a; Law and Jacobsen, 2010; Lister et 
al., 2009; Ramsahoye et al., 2000; Suzuki 
and Bird, 2008; Tomizawa et al., 2011; 
Zemach et al., 2010). It is a highly dynamic 
process during germ cell and pre-
implantation development but is relatively 
static during development of somatic tissues 
in case of mammals. 5mC has been found to 
be the sole methylation product in higher eu-
karyotes, where the methylation occurs not 
only in sequence-specific but also in a locus-
specific manner. In mammalian genomes 
(especially in somatic cells), methylation of 
cytosine predominantly occurs at CpG dinu-
cleotides, whereas, a fraction of 5mC is as-
sociated with non-CG contexts in embryonic 
stem cells (Lister et al., 2009). CpG motifs 
are under-represented in mammals and tend 
to cluster in the high density regions, re-
ferred to as CpG islands. Studies related to 
5mC distribution have shown that the ma-
jority (70–80 %) of CpGs are methylated, 
EXCLI Journal 2014;13:592-610 – ISSN 1611-2156 
Received: March 03, 2014, accepted: May 08, 2014, published: May 27, 2014 
 
 
593 
except for those localized in CpG islands. 
Traditionally, 5mC when localized at CpG 
islands are important transcriptional silencers 
at gene promoters. The cytosine methylation 
typically leads to strong and heritable gene 
silencing. The epigenetic role of 5-methyl-
cytosine has been widely studied and was 
found to be crucial in a variety of cellular 
processes including development gene regu-
lation, differentiation, genomic imprinting, 
silencing of transposable elements, X-
chromosome inactivation and others (Bird, 
2002). Because of its significance and herit-
ability, 5mC is often called the fifth base of 
DNA. The occurrence of 5mC containing 
photoproducts in UV irradiated DNA is still 
controversial (Rastogi et al., 2010). Howev-
er, on the basis of HPLC and Mass spec-
trometry analyses a new photoproduct of 
5mC has also been characterized (Su et al., 
2010). It has been assumed by various group 
of workers that 5mC display a certain level 
of plasticity during development (Bernstein 
et al., 2007; Mohn and Schubeler, 2009), 
therefore, they needs to be rapidly removed 
by DNA demethylation processes at certain 
developmental stages. However, the mecha-
nisms of DNA demethylation have always 
remained controversial (Ooi and Bestor, 
2008; Wu and Zhang, 2010).  
DNA hydroxymethylation, is a recently 
identified type of DNA modification in 
which the hydrogen atom at the C5-position 
in cytosine is replaced by a hydroxymethyl 
group, and whose, importance to biology and 
its role as an epigenetic marker have only 
been appreciated during the past few years. 
The presence of 5-hydroxymethylcytosine 
(5-hmC) has been observed in the genomes 
of many different organisms, and in mam-
mals its levels are the highest in the brain 
and other tissues of the central nervous sys-
tem (Globisch et al., 2010; Kinney et al., 
2011; Kriaucionis and Heintz, 2009; Michae-
li et al., 2013). 5-hmC is generated through 
oxidation of 5mC by the Ten-Eleven Trans-
location (TET) family of methylcytosine di-
oxygenases (Guo et al., 2011; Hashimoto et 
al., 2012; Wu and Zhang, 2011a;) and is 
considered to be a possible intermediate step 
in a replication-independent DNA demethyl-
ation pathway (Guo et al., 2011; Tahiliani et 
al., 2009; Wu and Zhang, 2010).  
The discovery of a hydroxylated form of 
5mC (5-hmC) (Kriaucionis and Heintz, 
2009) and the TET family of enzymes re-
quired for its conversion (Tahiliani et al., 
2009) has now offered insight into DNA 
methylation pathway involved in many bio-
logical processes including those pertaining 
to nervous system function (Kass et al., 
2013). These modified bases may then func-
tion as DNA demethylation intermediates 
subject to deamination, glycosylase-
dependent excision, and repair resulting in a 
reversion back to unmodified cytosine (Bhu-
tani et al., 2011; Branco et al., 2012). How-
ever, recently, the DNA methyltransferases 
(DNMT) enzymes (Tan and Shi, 2012) has 
also been ascribed a role in the 5-hmC pro-
duction, suggesting that this species may not 
be exclusively considered an intermediate of 
the 5mC demethylation process, but also an 
important epigenetic marker enriched within 
gene bodies, promoters, and transcription 
factor binding sites, where it may influence 
gene expression (Hahn et al., 2013; Mellén 
et al., 2012; Szulwach et al., 2011a) and 
thus, regulates the pluripotency of stem cells, 
cellular development, aging, and carcinogen-
esis (Liutkeviciute et al., 2009). Three major 
types of DNA methyltransferases are active 
on mammalian genomes (Figure 1A). 
DNMT1, the maintenance methyltransferase, 
maintains the genome-wide methylation pat-
terns during replication as it preferentially 
methylates hemi-methylated cytosines in 
CpG sequences (Bestor, 1992; Li et al., 
1992). DNMT3A and DNMT3B can methyl-
ate unmethylated CpG sequences and hence 
function as de novo methyltransferases 
(Okano et al., 1998 a). DNMT3L has no cat-
alytic activity but recruits DNMT3A and 
DNMT3B to their targets by recognizing nu-
cleosomes that carry unmethylated histone 
H3 lysine 4 (H3K4) (Aapola et al., 2000; 
Bourc’his and Bestor, 2004; Bourc’his et al., 
2001; Hata et al., 2002; Ooi et al., 2007). 
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Figure 1: Schematic representation of the human DNA methyltransferase (A) and Tet family proteins 
(B). Dnmts share a conserved catalytic domain (MTase), but differ in their N-terminal regulatory re-
gions. Dnmt1 contains a proliferating cell nuclear antigen (PCNA) binding domain, a pericentric heter-
ochromatin targeting sequence (TS), a CXXC domain, and two bromo adjacent homology domains 
(BAH). Dnmt3A and 3B comprise a PWWP domain named after a conserved Pro-Trp-Trp-Pro motif 
and an ATRX-Dnmt3-Dnmt3L (ADD) domain also known as the PHD (plant homeodomain) domain. 
Tet 1, 2, 3 proteins contain a cysteine-rich (Cys) region and a double-stranded β-helix (DSBH) fold re-
sponsible for catalytic activity (modified from Kriukiene et al., 2012). 
 
 
DOMAIN STRUCTURE AND DISTRI-
BUTION OF TET-FAMILY PROTEINS 
TET proteins are mammalian homologs 
of the trypanosome base J binding proteins, 
JBP1 and JBP2, that contain catalytic motifs 
typical of Fe(II)- and 2-oxoglutarate (2OG)-
dependent dioxygenases and require α-
ketoglutarate as a co-substrate for enzymatic 
activity (Figure 1B) (Iyer et al., 2009; Tahi-
liani et al., 2009). In the N-terminal part, the 
Tet proteins possess a CXXC domain, a bi-
nuclear Zn-chelating domain found in certain 
chromatin-associated proteins such as Dnmt1 
methyltransferase, and other elements which 
mediate interactions with multiple compo-
nents in the cell (Xu et al., 2011b; Zhang et 
al., 2010). Unlike the CXXC domains in oth-
er proteins, such as, DNMT1, mye-
loid/lymphoid or mixed-lineage leukemia 
(MLL) and CXXC finger protein 1 (CFP1, or 
CXXC1), which are known to bind un-
methylated CpG dinucleotides (Cierpicki et 
al., 2010; Song et al., 2011b; Xu et al., 
2011a), the function of this domain in Tet1 
and Tet3 is largely unknown.Various group 
of workers have reported that CXXC domain 
of TET1 recognizes not only unmodified cy-
tosine but also 5mC and 5-hmc, and it pre-
fers to bind to regions in the genome of high 
CpG content (Xu et al., 2011b; Zhang et al., 
2010). Depending on this feature, genome-
wide mapping of Tet1 binding by ChIP-seq 
approaches revealed its enrichment around 
transcription start sites (TSSs) in mouse ES 
cells (Figure 2) (Xu et al., 2011b; Williams 
et al., 2011; Wu et al., 2011). In addition, to 
the functional domains of Tet protein action, 
a spacer region, common to all TET family 
members but with varying length bridges the 
two parts of the disconnected DSBH enzy-
matic domain. The functional significance of 
this spacer region is currently unknown. 
However, recently, Upadhyay et al. (2011) 
have revealed that the spacer region of Tet1 
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has significant sequence similarity to the C-
terminal domain (CTD) of RNA polymerase 
II of Saccharomyces cerevisiae. All three 
members of the TETs (TET1–TET3) have 
been shown to specifically catalyze the con-
version of 5mC to 5-hmC as well as its fur-
ther oxidation into 5-formylcytosine (5-fC) 
and 5-carboxylcytosine (5-caC), in the pres-
ence of ATP respectively (Figure 3) (Ito et 
al., 2010; 2011; He et al., 2011b). 
The distribution of TET1/2/3 proteins 
vary in different tissue (Cimmino et al., 
2011; Szwagierczak et al., 2010; Tahiliani et 
al., 2009) (Table 1). 5-hmC is abundant in 
the brain (~40 % and ~13 % as abundant as 
5mC in Purkinje and granule cells, respec-
tively), but is present at lower levels in other 
mouse tissues (Kriaucionis and Heintz, 
2009). 5-hmc is detected in mouse ESCs 
(~7-10 % as abundant as 5mC) but is unde-
tectable in human T cells and in mouse den-
dritic cells (Tahiliani et al., 2009).  
TET1 was first reported to have a role in 
maintaining the pluripotent state of embry-
onic stem cells (ESCs) (Ito et al., 2010), and 
together with TET2, it also regulates the cell 
lineage commitment of ESCs (Koh et al., 
2011). TET2 modulates the balance between 
self-renewal and differentiation in hemato-
poietic stem cells, making them critical for 
normal myelopoiesis; TET2 mutations are 
seen in multiple types of leukemia and also 
 
 
Figure 2: Structure and function of Tet family proteins in mouse.The Tet protein family contains three 
members: Tet1, Tet2 and Tet3. All Tet proteins contains a catalytic C-terminal CD domain having cys-
teine-rich and a double-stranded-β-helix, DSBH regions) that exhibits 2-oxoglutarate (2-OG)- and iron 
(II)-dependent dioxygenase activity. A spacer region of varying length is also present in the CD do-
main. The N-termini of Tet1 and Tet3, but not Tet2, contain a CXXC domain, which mediates their di-
rect DNA-binding ability. There is also an unique PRK12323 (DNA polymerase III subunits gamma 
and tau; provisional) domain in Tet3, whose function is still not clear. a.a.: amino acids (modified from 
Tan and Shi, 2012). 
 
 
 
Figure 3: TET proteim mediated oxidation reaction.TET family proteins oxidize 5mC into 5hmC in the 
presence of 2-OG and iron. 5mC and 5hmC can also be further oxidized mainly to 5caC by Tet 
proteins in the presence of ATP.  
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Table 1: Proteins involved in cytosine modification (modified from Saitou et al., 2012) 
Protein Function Tissue Distribution References 
DNMT 1 Methylation of hemimethylated CpGs during DNA replication 
Highly expressed in proliferat-
ing cells (ubiquitous expres-
sion) 
Bestor et al., 1988;  
Lei et al., 1996 
DNMT 2 Methylation of small RNA 
High expression in heart, kid-
ney and testis(ubiquitous ex-
pression) 
Goll et al., 2006;  
Okano et al., 1998b 
DNMT 3A 
DNA methylation establishment in 
early development and germ cells 
(Involve in imprint establishment 
during gametogenesis with 
DNMT3L) 
Highly expressed in embryonic 
tissue and undifferentiated 
ESCs (ubiquitous expression) 
Kaneda et al., 2004;  
Okano et al., 1998a, 1999  
DNMT 3B 
DNA methylation establishment in 
early development and germ cells 
(crucial for methylation of pericen-
tromeric major and minor satellite 
repeats) 
Highly expressed in embryonic 
tissue and undifferentiated 
ESCs (ubiquitous expression) 
Kaneda et al., 2004;  
Okano et al., 1998a,1999; 
Ueda et al., 2006 
DNMT 3L 
Non-catalytic activity; essential for 
the establishment of imprints in oo-
cytes and for silencing of dispersed 
repeatedsequences in male germ 
cells 
Specific expression in germ 
cells during gametogenesis 
and embryonic stages 
Bourc’his and Bestor, 2004;  
Hata et al., 2002;  
Webster et al., 2005 
NP95 
(UHRF1) 
Recruitment of DNMT1 into the rep-
lication foci 
Highly expressed in proliferat-
ing cells (ubiquitous expres-
sion) 
Bostick et al., 2007; 
Fujimori et al., 1998;  
Sharif et al., 2007 
TET 1 
Conversion of 5mC to 5hmC; limits 
accessibility of DNA to DNMTs by 
binding strongly to unmethylated 
CpG-rich regions via its CXXC do-
main 
Highly expressed in ESCs 
Dawlaty et al., 2011;  
Ito et al., 2010;  
Koh et al., 2011;  
Szwagierczak et al., 2010;  
Tahiliani et al., 2009;  
Xu et al., 2011b 
TET 2 Conversion of 5mC to 5hmC 
Expressed in ESCs and hema-
topoietic cells(expression in 
almost all tissues) 
Szwagierczak et al., 2010; 
Figueroa et al., 2010;  
Ito et al., 2010;  
Ko et al., 2010;  
Koh et al., 2011;  
Langemeijer et al., 2009;  
Moran-Crusio et al., 2011; 
Quivoron et al., 2011 
TET 3 Conversion of 5mC to 5hmC 
Highly expressed in oocyte 
and zygote (expression in 
NSCs, lung, spleen and pan-
creas, etc.) 
Gu et al., 2011;  
Iqbal et al., 2011;  
Wossidlo et al., 2011;  
Ito et al., 2010;  
Szwagierczak et al., 2010 
AID 
Deamination of cytosine to uracil in 
ssDNA, of 5mC to thymine and of 
5hmC to 5hmU 
Expressed in activated B cells 
and testis; expressed in oo-
cytes, ESCs and PGCs (low 
level) 
Muramatsu et al., 2000;  
Morgan et al., 2004; 
Bhutani et al., 2010;  
Popp et al., 2010;  
Guo et al., 2011 
APO-
BEC1 
Deamination of cytosine to uracil in 
RNA and DNA, of 5mC to thymine 
and of 5hmC to 5hmU 
Expressed in small intestine 
Hirano et al., 1996;  
Morrison et al., 1996;  
Navaratnam et al., 1993;  
Teng et al.,1993;  
Morgan et al., 2004;  
Guo et al., 2011 
5hmC - 5-hydroxymethylcytosine, 5hmU - 5-hydroxymethyluracil, 5mC - 5-methylcytosine, AID - activation-induced deam-
inase, AP - apurinic/apyrimidinic, APOBEC1 - apolipoprotein B mRNA editing enzyme, catalytic polypeptides, DNMT - 
DNA methyltransferase, ESC - embryonic stem cells, IAP - intracisternal A particle, IgM - immunoglobulin M, LINE1 - long 
interspersed nuclear element 1, NSC - neural stem cell, PGC - primordial germ cell, siRNA - short interfering RNA, ssDNA - 
single stranded DNA, TET - ten-eleven translocation, UHRF1 - ubiquitin-like, containing PHD and RING finger domains 1. 
 
EXCLI Journal 2014;13:592-610 – ISSN 1611-2156 
Received: March 03, 2014, accepted: May 08, 2014, published: May 27, 2014 
 
 
597 
in patients with diverse myeloid malignan-
cies (Ko et al., 2010, 2011; Li et al., 2011; 
Moran-Crusio et al., 2011; Quivoron et al., 
2011; Shide et al., 2012). Shide et al. (2012) 
reported the critical role of TET2 in survival 
and HSC homeostasis after in vivo analysis 
of its function in Ayu17-449 (TET2 trap) 
mice. TET3 contributes to the global DNA 
methylation erasure during the zygote stage 
of embryonic development (Gu et al., 2011; 
Inoue and Zhang, 2011). These studies to-
gether, demonstrates the critical role of TET-
mediated 5-hmC modification in develop-
mental processes and the possibility that 
dysregulation of 5-hmC may be associated 
with disease. 
In mouse ESCs, Tet1 and Tet2 are highly 
expressed but are rapidly downregulated up-
on differentiation (Ito et al., 2010; Koh et al., 
2011; Saitou et al., 2012; Tahiliani et al., 
2009), whereas Tet3 is expressed at very low 
levels in ES cells and upregulated during ES 
cell differentiation. Dawlaty et al. (2011) 
demonstrated that Tet1 knockout ESCs 
showed a ~35 % reduction in 5-hmc levels, 
and exhibit only subtle changes in gene ex-
pression, are pluripotent and support full-
term mouse development in the Tetraploid 
complementation assay. Koh et al. (2011) 
reported that both Tet1 and Tet2 are down-
stream targets of key pluripotency factors.  
Wang et al. (2012) have reported that 5-
hmC-mediated epigenetic pathways play 
evolutionarily conserved roles in the mam-
malian brain. In neuronal cells, 5-hmC is not 
enriched at enhancers but associates prefer-
entially with gene bodies of activated neu-
ronal function-related genes. Within these 
genes, gain of 5-hmC is often accompanied 
by loss of H3K27me3. Enrichment of 5-hmC 
is not associated with substantial DNA de-
methylation suggesting the potential of 5-
hmc as a stable epigenetic mark. Functional 
perturbation of the H3K27 methyltransferase 
Ezh2 or of Tet2 and Tet3 leads to defects in 
neuronal differentiation suggesting that for-
mation of 5-hmC and loss of H3K27me3 co-
operate to promote brain development (Hahn 
et al., 2013). 
The presence of 5-hydroxymethylcyto-
sine in DNA was first observed in T-even 
bacteriophages (Wyatt and Cohen, 1953). In 
T-even phages, 5-hydroxymethylated cyto-
sine is incorporated into the genome during 
DNA synthesis, and is subsequently modi-
fied by phage α- and β-glucosyltransferases, 
creating a highly glucosylated DNA contain-
ing 5-glucosyloxymethylcytosine (glc-hmC) 
residues. The precursor nucleotide, 2’-deoxy-
5-hydroxymethylcytidine- 5’-monophosphate 
(dhmCMP), is produced by enzymatic addi-
tion of a methylene group at the 5-position of 
dCMP. This reaction is mechanistically simi-
lar to DNA C5-methylation as it involves the 
formation of a covalent intermediate between 
a cysteine residue from an enzyme and the 
C6-position of cytosine (Warren, 1980). A 
similar modified base J (5-(β-D-glucosyl)-
oxymethyluracil) is present in DNA of flag-
ellated protozoa of the order of Kinetoplas-
tida and unicellular alga Euglena gracilis 
(Borst and Sabatini, 2008). However, dis-
covery of physiologically relevant DNA 
modification in mammals, such as in mouse 
neurons and ESCs (Kriaucionis and Heintz, 
2009; Tahiliani et al., 2009), is a more recent 
novel finding. 
The chemical oxidation of 5mC and 
thymine is considered to be the major source 
of these hydroxymethylated nucleobases in 
higher eukaryotes. 5-hmC can be formed at 
5mC sites in response to oxidative stress in 
vitro (Wagner and Cadet, 2010). Oxidation 
of thymine residues in DNA to hmU was 
considered to be an important source of en-
dogenous oxidative DNA damage. 5mC is 
slightly more reactive towards hydroxyl rad-
ical attack than is thymine and it was pre-
dicted that in human cells, ~20 5mC residues 
would be oxidized to hmC per cell per day 
(Planechaud et al., 1997). 
Valinluck et al. (2004) have reported that 
5-hmC may also be a biological end-product 
of demethylation, as methyl-CpG binding 
proteins have a significantly lower affinity 
for 5-hmC. The ability of DNMT1 to recog-
nize 5-hmC under in vitro condition is very 
poor (Valinluck and Sowers, 2007); thus, 5-
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hmc might passively convert into cytosine 
during replication. However, recently, it has 
been worked out by Frauer et al. (2011) that 
Np95, which recruits DNMT1 to replication 
foci, recognizes 5-hmC as efficiently as it 
does 5mC, raising the possibility that 5-hmC 
may have the same capacity as 5-mC for 5-
mC propagation during replication. 
Szulwach et al. (2011b) reported that 5-
hmC-mediated epigenetic modification is 
critical in neurodevelopment and diseases 
both in mice and human. The kinetics study 
of hydroxymethylation during the first cell 
stage have shown that hydroxymethylation 
remains very low in the maternal pronucleus 
while it increases in the paternal one, in par-
allel to demethylation (Inoue and Zhang, 
2011; Iqbal et al., 2011; Wossidlo et al., 
2011; Ruzov et al., 2011; Gu et al., 2011). 
Based on their work on mouse zygote Salvi-
ang et al. (2012) hypothesized that 5-
hydroxymethylcytosine is not a simple in-
termediate in an active demethylation pro-
cess and could play a role of its own during 
early development. 
The presence of 5-hmC within eukaryotic 
genomes was unknown mainly because 
standard methods for detection of 5-methyl-
cytosine (5-mC) cannot distinguish between 
this base and 5-hmC (Huang et al., 2010; 
Münzel et al., 2010a; Jin et al., 2010). A 
newly developed method for single-
nucleotide resolution 5-hmC sequencing, 
based on oxidative conversion of 5-hmC to 
5-formyl-cytosine and its further bisulfite 
conversion to uracil was given by Booth et 
al. (2012). Overall, 5-hmC content might al-
so be determined via selective chemical la-
beling with β-glucosyltransferase of 5-hmC 
by a glucose moiety containing an azide 
group modified, for example, by biotin (Pas-
tor et al., 2011; Song et al., 2011a). Wanunu 
et al. (2010) reported another approach using 
electric signal for detection on a DNA solu-
tion flown through nanopores. However, to 
understand the principles of recognition and 
binding of 5-hmC in biological context re-
quires its atomic structure. The interaction of 
5-hmC-modified DNA with the SET and 
RING-associated domain of the Uhrf1 pro-
tein that belongs to the big family of 5-mC 
binding proteins was studied by crystal struc-
ture and molecular dynamics analyses (Frau-
er et al., 2011) and it was found that 5-hmC 
base is flipped out of the DNA double helix 
and that the 5-hmC hydroxyl group partici-
pates in hydrogen bonding, which helps to 
stabilize the interaction. Expansion of studies 
on 5-hmC was enabled by the development 
of suitable phosphoramidites (Münzel et al., 
2011). These authors found that both 5-hmC 
and 5-mC were not causing any insertion of 
wrong nucleotides even by low-fidelity pol-
ymerases, and therefore, concluded that posi-
tion 5 of cytosine is the ideal place to store 
epigenetic information. By using X-ray dif-
fraction Renciuk et al. (2013) reported that 
the cytosine modification (5mC and 5-hmC) 
neither influences the helical structure of B-
DNA nor the thermodynamics. 
 
ROLES OF 5-HMC 
(a) DNA methylation and gene expression 
Multiple pathways have been suggested 
by various workers for 5-hmc mediated regu-
lation of the DNA methylation dynamics and 
gene transcription. 5-hmC was found to be 
more sensitive to deamination than 5mC by 
activation-induced deaminase (AID), and the 
deamination product, 5-hydroxymethyluracil 
(5hmU), activates base-excision repair 
(BER) pathway-mediated demethylation 
(Guo et al., 2011), suggesting one possible 
way to acheive DNA demethylation. Recent-
ly, it has been shown that Tet proteins can 
oxidize 5mC not only to 5-hmc but also to 
5fC and 5caC, which can subsequently be 
recognized and excised by thymine DNA 
glycosylase (TDG) in vitro and in vivo (He et 
al., 2011b; Ito et al., 2011; Pfaffeneder et al., 
2011; Zhang et al., 2012). The gradual loss 
of 5-hmC, 5fC and 5caC, associated with the 
paternal genome in the zygote during preim-
plantation development suggested a domi-
nant mechanism of passive DNA demethyla-
tion at this developmental stage (Inoue and 
Zhang, 2011; Inoue et al., 2011; Oda et al. 
2009). 5-hmC is important for proper gene 
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transcription as it directs the dynamic re-
modeling and organization of the chromatin 
structures (Tan and Shi, 2012). Jin et al. 
(2010) reported that many methyl-CpG-
binding domain (MBD) proteins, such as 
MBD1, MBD2, methyl CpG-binding protein 
2 (MECP2) and MBD4, do not bind 5-hmC 
in vitro. However, recently it has been pro-
posed that Tet1 is associated with the 
Mbd3/NuRD complex in mouse ES cells and 
that Mbd3 can bind 5-hmC and unmodified 
cytosine, but not 5mC, in vitro (Yildirim et 
al., 2011). Hashimoto et al. (2012) based on 
his studies on DNA methyltranferases re-
ported the high intrinsic activity of DNMT1 
towards the hemi-methylated CpG substrate 
but a greatly reduced activity for the hemi-
hydroxymethylated CpG substrate in methyl 
transfer assays in vitro, whereas the 
DNMT3A and DNMT3B exhibited equal ac-
tivities on unmodified, hemimethylated and 
hemi-hydroxymethylated CpG substrates. 
Based on these studies it can be considered 
that 5-hmC acts as a stable epigenetic marker 
that directly influence genome structure and 
function, instead of being simply an inter-
mediate of DNA demethylation. 
 
(b) Mammalian development  
(i) Mouse primordial germ cells and gametes 
Gene knockout strategies have been used 
to investigate the role of DNA methylation 
and demethylation involving TET family 
proteins and 5-hmc in mammalian develop-
ment. The mouse oocyte and sperm develop 
from primordial germ cells (PGCs) which 
are specified from epiblast cells and migrate 
into the gonad region at embryonic day (E) 
7.25. The genome-wide DNA demethylation, 
erasure of genomic imprints, and large-scale 
chromatin remodeling takes place at E11.5 
(Hajkova et al., 2008; Kota and Feil, 2011). 
Both Tet1 and Tet2 are expressed in E11.5 
and E12.5 PGCs but less so in oocytes and 
zygotes, whereas Tet3 is highly expressed in 
oocytes but not in PGCs (Hajkova et al., 
2010; Surani and Hajkova, 2010; Gu et al., 
2011). The development of PGCs, and sub-
sequently of spermatocytes or oocytes, is 
normal in Tet1 or Tet2 knockout mice (Daw-
laty et al., 2011; Ko et al., 2011; Li et al., 
2011; Moran-Crusio et al., 2011; Quivoron 
et al., 2011), whereas some workers estab-
lished PGC-conditional Tet3 knockout mice 
and found that oogenesis and spermatogene-
sis are normal when Tet3 is absent in PGCs 
(Gu et al., 2011). 
(ii) Mouse zygote 
When DNA methylation ends up in pa-
rental genome rapidly after fertilization, then 
DNA demethylation takes place (Oswald et 
al., 2000). Recently, it has been reported that 
the oxidation of 5mc to 5-hmc takes place 
only in paternal but not in the maternal pro-
nucleus (Iqbal et al., 2011; Wossidlo et al., 
2011). In contrast to Tet1 and Tet2, TET 3 
are highly expressed in oocytes and fertilized 
zygotes but disappears rapidly during cleav-
age (Gu et al., 2011; Iqbal et al., 2011; Wos-
sidlo et al., 2011). Gu et al. (2011) showed 
maternal Tet3 to be the key enzyme catalyz-
ing 5mC into 5-hmC in the paternal pronu-
clei of developing zygotes. Nakamura et al. 
(2007) reported the presence of DNA de-
methylation and 5-hmc in the maternal pro-
nuclei of Stella (Dppa3) null zygotes. Gu et 
al. (2011) reported the requirement of oxida-
tion of 5mc to 5-hmc in oocytes during so-
matic cell nuclear transfer.  
(iii) Mouse pre- and post-implantation em-
bryos and in ES cells 
High levels of Tet1 and 5-hmC are found 
in mouse ES cells, inner cell mass of the 
mouse blastocyst, and in cells of the early 
mouse epiblast (Ito et al., 2010; Koh et al., 
2011; Ruzov et al., 2011). Recently, it has 
been found that the shRNA-mediated knock-
down of Tet1, but not Tet2 or Tet3, led to the 
spontaneous differentiation of mouse ES 
cells even in the presence of LIF (Ito et al., 
2010). However, others believe that Tet1 is 
not required for maintaining the self-renewal 
of mouse ES cells (Koh et al., 2011; Wil-
liams et al., 2011; Xu et al., 2011b). The role 
of knockdown and knockout of Tet1 in forc-
ing the transdifferentiation of mouse ES cells 
into trophoblasts has not been detected in vi-
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vo (Dawlaty et al., 2011; Ito et al., 2010), 
and Tet1–/– and Tet2–/– mice appeared to 
develop normally, appear healthy through 
adulthood and were found to be fertile (Daw-
laty et al., 2011; Li et al., 2011; Moran-
Crusio et al., 2011; Quivoron et al., 2011). 
Gu et al. (2011) showed that homozygous 
mutation of Tet3 led to neonatal lethality, 
highlighting its importance in the develop-
ment of multiple organs during embryogene-
sis. Thus, Tet1/Tet2 and 5-hmC plays an im-
portant but redundant role in the regulation 
of postimplantation embryonic development. 
(iv) Mouse postnatal development 
The role of 5-hmC dynamics in postnatal 
neurodevelopment and brain function and 
their abnormality leading to neural disorders 
has been worked out by various workers. 5-
hmc is found to be present in almost all or-
gans and tissues of mice but with varying 
levels (Ito et al., 2010; Li et al., 2011). The 
genome-wide analysis of brain revealed that 
5-hmC levels in the cerebellum and hippo-
campus of adult mice are higher than those 
observed in postnatal day (P) 7 mice (Szul-
wach et al., 2011b). MECP2, a methyl-CpG-
binding protein plays an important role in 
neural development and brain function (Lew-
is et al., 1992). Amir et al. (1999) reported 
that humans suffer from Rett syndrome, a 
neurodevelopmental disorder due to the mu-
tations in MECP2. Szulwach et al. (2011b) 
using Mecp2 knockout and knockin mice 
found that the overall abundance of 5-hmC 
in the cerebellum was negatively correlated 
with Mecp2 dosage. Recent evidence sug-
gests that Tet2 and 5-hmC are also associat-
ed with postnatal development of the hema-
topoietic lineage, and alteration of Tet2 ex-
pression or the levels of 5-hmC may disrupt 
the homeostasis of cells and ultimately lead 
to abnormalities in hematopoietic cell prolif-
eration and maturation (Albano et al., 2011; 
Chou et al., 2011; Weissmann et al., 2012). 
In TET knockout phenotype (Tet2–/–) of 
mice an abnormality in myeloid lineage dif-
ferentiation and spontaneous leukemia but 
with a overall normal growth appeared (Ko 
et al., 2011; Li et al., 2011; Moran-Crusio et 
al., 2011; Quivoron et al., 2011). Gu et al. 
(2011) showed that although the Tet3–/– 
phenotype was neonatal lethal, the exact 
functions of Tet3 protein in postnatal devel-
opment are largely unknown and need fur-
ther investigation. 
(v) Human cerebellum development 
5-hmC is abundant in human ESCs 
(hESCs) and brain regions, and the genomic 
features of 5-hmC in hESCs has been well 
characterized by Szulwach et al. (2011a) and 
Stroud et al. (2011). Similar to hESCs, in 
cerebellum, 5-hmC displayed a bimodal dis-
tribution around transcription start sites 
(TSS) and was enriched in gene body re-
gions. In comparison with hESCs, less 5-
hmC was found at CpG islands and CpG 
shores, suggesting that CpG islands and 
shores may have a specific protective mech-
anism against 5-hmC modification in cere-
bellum. Wang et al. (2012) have reported a 
positive correlation between 5-hmC levels 
and cerebellum development in humans. Ge-
nome-wide profiling reveals that 5-hmC is 
highly enriched on specific gene regions in-
cluding exons and particularly the untrans-
lated regions (5’UTRs), but it is depleted on 
introns and intergenic regions in both the fe-
tal and adult cerebellum samples. Further-
more, they have also identified fetus-specific 
and adult-specific differentially hydroxy-
methylated regions (DhMRs), most of which 
overlap with genes and CpG island shores. 
Surprisingly, during development, DhMRs 
are highly enriched in genes encoding 
mRNAs that can be regulated by fragile X 
mental retardation protein (FMRP), some of 
which are disrupted in autism, as well as in 
many known autism genes. 
 
(c) Human diseases 
The crucial role of 5-hmc for normal 
neuronal function being evident with the mu-
tation of MeCP2 protein, causing Rett syn-
drome, an autism disorder characterized by 
severe deterioration of neuronal function af-
ter birth (Szulwach et al., 2011b). The role of 
Tet proteins and 5-hmC has also been stud-
ied in the context of haematopoiesis and 
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cancer. Aberrant DNA methylation is a 
hallmark of cancer, and cancer cells often 
display global hypomethylation and promot-
er hypermethylation (Esteller, 2008). The 
Tet1 gene was originally identified through 
its translocation in acute myeloid leukemia 
(AML). Later, somatic Tet2 mutations were 
tified in patients with a variety of myeloid 
malignancies, including myelodysplastic 
syndromes (MDS), chronic myelomonocytic 
leukemia (CMML), acute myeloid leukemias 
and many others (Ko et al., 2010). Figueroa 
et al. (2010) demonstrated that Tet2 muta-
tions in AML patients are predominantly as-
sociated with a DNA hypermethylation phe-
notype. 
Among all the members of TET family, 
TET2 is the most studied genes in MDS and 
other types of leukemia and whose mutations 
or dysregulation might lead to lethality. In 
case of myeloid malignancies, it has been re-
ported as one of the most frequently mutated 
genes (Albano et al., 2011; Chou et al., 2011; 
Weissmann et al., 2012). Some of the muta-
tion sites in TET2 affects the residues within 
the catalytic domain and could thus damage 
catalytic activity, whereas, many mutations 
appear unrelated to enzymatic activity (Ko et 
al., 2010). Recent studies on isocitrate dehy-
drogenase (IDH) gene which catalyzes the 
conversion of isocitrate to 2-oxoglutarate 
(2OG) also suggests the involvement of 5-
hmC in cancer. The mutations in the iso-
citrate dehydrogenase gene IDH1/2 in pa-
tients suffering from AML were found to 
stimulate the accumulation of 2-
hydroxyglutarate (2-HG) in cells (Klose et 
al., 2006). This metabolite impairs catalytic 
activity of many 2-oxoglutarate-dependent 
enzymes, including Tet proteins, by compet-
ing with its co-substrate 2OG. Thus, these 
results suggest that the deficiencies in both 
IDH and Tet genes contribute to cancer de-
velopment via a common disease mechanism 
that leads to altered 5mC and 5-hmC pat-
terns. However, the role of TET1 in hemato-
poietic development and leukemogenesis 
still remains uncertain. The levels of 5-hmC 
have been found to be decreased in a broad 
range of solid tumors, including glioma, co-
lon cancer, breast cancer and melanoma (Li 
and Liu, 2011; Jin et al., 2011a; Haffner et 
al., 2011). 
 
(d) Transcriptional regulation 
The abundance of Tet1 and 5-hmc at the 
promoter sites suggests a role for the Tet-
mediated hydroxymethylation in transcrip-
tional regulation (Wu and Zhang, 2011b). 
Tet1 and 5-hmc are enriched at 5' gene regu-
latory regions of various pluripotency fac-
tors, such as Nanog, Esrrb and Tcl1 thereby 
promoting the transcription of the gene. 
Therefore, the depletion of Tet1/2 has been 
reported to decrease the expression of a 
group of genes, including these pluripotency-
related factors (Ficz et al., 2011; Ito et al., 
2010; Wu et al., 2011). In undifferentiated 
mouse ES cells, Tet1, probably in conjunc-
tion with Tet2, are required for promoting 
transcription of a cohort of pluripotency fac-
tors by maintaining a hypomethylated state 
at their promoters. Williams et al. (2011) re-
ported that the colocalization of TET1 the 
SIN3A co-repressor brings about the gene 
repression. 
 
METHODS FOR IN VITRO 
PRODUCTION AND ANALYSIS  
OF 5-HMC IN DNA 
The chemical synthesis of hmC contain-
ing oligonucleotides was first worked out by 
Planechaud et al. (1997), and is currently be-
ing used by the majority of commercial sup-
plies. DNA polymerase-dependent processes 
(including PCR) utilising commercial 2ʹ-
deoxynucleoside-5ʹ-triphosphate (dhmCTP) 
are being used for enzymatic incorporation 
of 5-hmC into DNA. Recently, chemo-
enzymatic reaction of DNA cytosine-5 me-
thyltransferases has been developed for in 
vitro sequence specific incorporation of 5-
hmC into DNA duplexes (Liutkevičiūtė et 
al., 2009). 
Following the discovery of 5-hmc, all the 
existing DNA methylation investigation 
methods needed to be re-evaluated as they 
were designed to distinguish only the two 
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epigenetic states of cytosine: methylated ver-
sus unmodified. Therefore, there is a need to 
develop methods having the ability to dis-
criminate between 5-hmC and 5mC in DNA. 
Previously, bisulfite sequencing (Huang et 
al., 2010) were widely used for DNA methy-
lation studies, in which the unmodified cyto-
sine readily forms a 5,6-dihydro-6-sulfonyl 
adduct in the presence of bisulfite, which 
undergoes hydrolytic deamination to uracil, 
and thus appears as T in DNA sequencing. 
5mC is very stable to bisulfite-promoted de-
amination and is subsequently read as nor-
mal C. Bisulfite reacts predominantly with 
the 5-hydroxymethyl group yielding a hydro-
lytically stable 5-sulfonylmethylcytosine 
(smC, also called cytosine 5-methylenesulfo-
nate), and thus hmC appears as C (Huang et 
al., 2010). In contrast, the products of hmC 
oxidation, caC and fC, are interpreted as un-
modified C (Booth et al., 2012) owing to 
their transient bisulfite-induced conversion 
to C. Thus, it is evident that bisulfite conver-
sion cannot discriminate between 5mC and 
hmC (Huang et al., 2010; Jin et al., 2010). 
Recently, two methods have been proposed 
that permit detection of hmC in bisulfite se-
quencing after chemical or enzymatic modi-
fications of hmC (Booth et al., 2012; Yu et 
al., 2012). 
Methyl-sensitive CG-specific restriction 
endonucleases that differentially cleave un-
methylated and methylated target sites are 
also an important tool for analysis of DNA 
methylation. Most of the restriction enzymes 
do not clearly discriminate between 5mC and 
5-hmC (Nestor et al., 2010) although some 
hmC-specific restriction endonucleases have 
recently been described (Wang et al., 2011). 
Radiolabeling strategies have also been used 
for analysis of hmC in DNA. In one such ap-
proach named ‘‘nearest neighbour analysis’’, 
single stranded DNA breaks are randomly 
introduced by DNaseI and then DNA poly-
merase and [α-33P]- dGTP is used to incorpo-
rate the radioactively labeled G nucleotide at 
the DNA breaks in the case when C is in the 
opposite strand. Then DNA is enzymatically 
hydrolysed to yield 3ʹ-nucleotides such that 
the radiolabeled phosphate group appears on 
a 5ʹ-neighbouring nucleotide (Kriaučionis 
and Heintz, 2009). Alternatively, another 
method with higher sensitivity is also being 
used in which the modified cytosine in CG 
dinucleotides can be enriched by using 
R.MspI or R.TaqI restriction endonucleases, 
that cleaves CCGG or TCGA sites, respecti-
vely, between the two pyrimidines, regard-
less of whether C, 5mC or hmC is present in 
the second position. The produced DNA 
fragments with 5ʹ-terminal CG sites are 33P-
labeled and DNA is degraded to 5ʹ-NMPs for 
thin layer chromatography (TLC) (Tahiliani 
et al., 2009). 
HPLC can also be used for the analysis 
of 5-hmc. hmC 2ʹ-deoxynucleoside elutes 
closely following, and is partially disguised 
by, a major peak of 2ʹ-deoxycytidine. Similar 
elution times on reverse-phase columns and 
similar UV spectra of C and hmC may com-
plicate detection of hmC in routine analyses 
of mammalian DNA using UV detection (Ito 
et al., 2011). But, this problem can be over-
come by the use of synthetic stable-isotope 
labeled internal standards in mass spec-
trometry detectors for reliable quantification 
of nucleosides (Münzel et al., 2010b). 
Genome-wide localization of hmC can 
also be detected by affinity enrichment based 
methods (Figure 4). Such methods rely on 
selective binding of short hmC containing 
DNA fragments (200-800 bp) to hmC-
specific antibodies or other hmC-binding 
proteins permitting their physical extraction 
from the rest of DNA for analysis using 
quantitative PCR, DNA microarrays or se-
quencing. Polyclonal and monoclonal anti-
bodies have been raised against hmC itself or 
the product of bisulfite treatment of hmC, 5-
sulfonylmethylcytosine (smC) (Ficz et al., 
2011; Jin et al., 2011b). During the last few 
years, methylated-DNA immunoprecipita-
tion (MeDIP), hMeDIP (hydroxymethylated-
DNA immunoprecipitation) are being widely 
used for 5-hmC profiling studies. 
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Figure 4: Analytical strategies for labelling and enrichment of hydroxymethylated DNA (modified from 
Kriukiene et al., 2012) 
 
 
The enzymatic glucosylation of 5-hmC, 
using T4 beta-glucosyltransferase (BGT) and 
the uridine-5’-diphospho-D-glucose (UDP-
glc) cofactor, to a much bulkier and distinc-
tive residue, 5-glucosyloxymethylcytosine is 
highly specific and selective for the 5-
hydroxymethyl group of hmC (or hmU). 
Such treatment can be used to attach tritium 
labeled glucose moieties from UDP-[3H] 
glucose to DNA, permitting direct quantifi-
cation of hmC by scintillation counting 
(Szwagierczak et al., 2010). JBP1 protein 
has been reported to selectively bind DNA 
fragments containing glucosylated hmC 
which can be used for selective isolation and 
analysis of hmC containing DNA (Robertson 
et al., 2011). 
Single-nucleotide resolution mapping of 
hmC residues in the genome can also be 
done by combining glucosylation of hmC 
and MspI restriction endonuclease digestion. 
R.MspI cleaves the CCGG target site if the 
second cytosine is unmethylated, methylated 
or hydroxymethylated, but glucosylation of 
hmC residues renders the sites resistant to 
MspI cleavage. Thus, glc-hmC DNA can be 
enriched and analysed using qPCR (Davis 
and Vaisvila, 2011), microarrays or next-
generation sequencing. 
The enrichment of 5-hmc in DNA is as-
sociated with chemical capture of glucosyl-
ated hmC residues (Pastor et al., 2011). Oxi-
dation of the glucose moiety with NaIO4 cre-
ates two reactive aldehyde groups which can 
be subsequently modified by commercially 
available aldehyde reactive probes contain-
ing biotin (Kriaučionis and Heintz, 2009). 
Nanopore sequencing has also been shown to 
directly discriminate 5-hmC from 5mC 
without any further chemical modifications 
of the base (Wanunu et al., 2010). Zhao and 
Xue (2012) developed a highly sensitive flu-
orescence polarization method for genome-
wide quantification of DNA methylation. In 
addition, to estimation of methylation level 
of submicrograms of lambda or human 
DNA, and of a 255-bp DNA segment con-
taining a single HpaII /MspI restriction site, 
fluorescence polarization (FP) based meas-
urement of DNA methylation (FPDM) was 
also applied to measure dose-dependent 
DNA hypomethylation in human embryonic 
kidney 293T cells treated with the DNA-
methyltransferase inhibitor 5-aza-dC. Song 
et al. (2012) used single-molecule real-time 
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(SMRT) DNA sequencing for detection of 5-
hydroxymethylcytosine (5-hmC) in genomic 
DNA. 
 
CONCLUSION 
5-Hydroxymethylcytosine (5-hmC) a 
newly discovered modified form of cytosine 
has been assumed to be an important epige-
netic modification having important role in 
development ageing and diseases. 5-hmC is 
generated through oxidation of 5mC by the 
Ten-Eleven Translocation (TET) family of 
methylcytosine dioxygenases and is consid-
ered to be a possible intermediate step in a 
replication-independent DNA demethylation 
pathway. The role of Tet proteins and 5hmC 
in development and disease has been widely 
studied during the past few years. Moreover, 
further investigations are needed to distin-
guish the catalytic activity-dependent and 
independent functions of Tet proteins. Most 
studies of Tet proteins and 5hmC have been 
done on mice, rats and human models, there-
fore, investigations are needed to be expand-
ed to other model systems (such as Xenopus, 
zebrafish and even non-vertebrates) in order 
to elucidate the evolutionally conserved 
functions of these proteins. 
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